Hepatocellular Carcinoma
Hepatocellular cancer progression linked to increase of CD4+ CD25+ regulatory T cells
Published in Immunotherapy Weekly, October 11th, 2006
"The immune response to tumor-specific antigens is typically unable to control the growth and spread of malignant cells. Accumulating evidence indicates that the suppressive effects of CD4+ CD25+ regulatory T-cells are at least partially responsible for the failure of immune-mediated elimination of tumor cells. We have studied 25 patients with HCC," scientists in Japan reported.
"The liver tissues with HCC were separated into the marginal region of tumor (peri-tumor region) and the non-tumor region distant from the tumor," explained X.H. Yang and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2006-10-11)
More Articles from Immunotherapy Weekly
- Allergy & Immunology
High-intensity ultrasound reduces allergenic properties of shrimp allergens - Allergy & Immunology
Lymphoblast and T helper cell proliferation affected by interleukin - Arthritis
Arthritic erosion is hindered by thrombospondin-1 peptide - Arthritis
E2F decoy ODN may provide useful approach for treatment of joint destruction in arthritis - Systemic Lupus Erythematosus
Systemic lupus erythematosus gene mutation linked to autoimmune diseases - Allergy & Immunology
Education leads to decrease in the use of antibiotics as a frontline therapy for sinusitis - More from this issue of Immunotherapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
